Skip to main content
Clinical Trials/IRCT20230529058336N1
IRCT20230529058336N1
Recruiting
Phase 3

Evaluation of Efficacy of Botulinum Toxin In The Treatment Of Acne Vulgaris: A Double-Blind Clinical Trial

Tehran University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acne vulgaris.
Sponsor
Tehran University of Medical Sciences
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with moderate to severe Acne based on global acne grading system criteria
  • Age between 18 and 55 years old

Exclusion Criteria

  • Older than 55 years old
  • Younger than 18 years old
  • Having a contraindication to receiving Botox
  • Having needle phobia
  • Pregnancy and breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials